The basics
What are peptides?
If you've heard the word "peptide" on a podcast, in the news, or from a friend who suddenly looks ten years younger, this page is for you. No jargon. No hype. Just what you need to know.
The short answer
Peptides are small chains of amino acids, the same building blocks that make up proteins. Your body produces hundreds of them naturally. They act as signaling molecules, telling your cells what to do: repair this tissue, produce more collagen, release growth hormone, reduce inflammation.
As you age, your body produces fewer of these signaling molecules. For example, GHK-Cu levels drop by over 60% between your twenties and your sixties. Peptide therapy replaces what your body used to make on its own. That's why people describe it less as "taking a drug" and more as "restoring something that was lost."
How are peptides different from supplements?
Supplements provide raw materials: vitamins, minerals, amino acids. Your body has to figure out what to do with them. This is why supplements take months to show effects, if they show any at all. Absorption rates for traditional supplements are typically 20-30%.
Peptides provide instructions. They don't give your cells building materials and hope for the best. They tell specific cells to perform specific actions. Absorption rates can reach 95%. And the effects are felt in days to weeks, not months. Semax, for example, changes gene expression in the brain within 20 minutes of nasal delivery.
Think of it this way:
Supplements are like delivering bricks to a construction site. Peptides are like sending an architect with a blueprint. The bricks are useful, but the architect gets the building finished.
Why are peptides in the news?
Two things happened. First, GLP-1 medications like Ozempic and Wegovy proved to the world that a single peptide can dramatically change health outcomes. The "P" in GLP-1 stands for "peptide." Suddenly, hundreds of millions of people understood that peptides work.
Second, the regulatory landscape is shifting. In February 2026, the government announced plans to reclassify approximately 14 peptides from restricted to legal for compounding. This means what was previously only available through gray-market channels will soon be prescribed by doctors and prepared by licensed pharmacies. You can track every compound's current FDA status on our regulatory tracker.
The combination of proven demand (GLP-1) and expanding access (reclassification) is creating the biggest shift in personalized health since hormone therapy went mainstream.
Are peptides safe?
The honest answer: it depends on the compound, the source, and how it's used. Some peptides have decades of research and FDA approval. Others have promising animal data but limited human trials. We think you deserve to know the difference.
That's why every compound on Pep has an evidence grade: strong, moderate, limited, or early research. We tell you exactly what's been proven in human studies and what's still based on animal data or clinical observation. For instance, Thymosin Alpha-1 has strong evidence from 30+ clinical trials, while BPC-157 has extensive animal data but limited human trials. We don't hype, and we don't dismiss.
Peptide therapy should always be guided by a licensed clinician. Sourcing, dosing, and administration all affect safety. Self-administration of gray-market products carries real risks, including contamination, incorrect dosing, and lack of medical oversight.
What can peptides help with?
Different peptides serve different goals. Here are the most common areas people use peptide therapy for:
Where do I start?
If you know what you want to improve, browse our compound library by goal. If you're not sure yet, try the goal matcher: answer a few questions and we'll suggest compounds based on your specific situation.
Stay informed. Get evidence-based peptide updates.
Be first to know when Pep's clinician service launches.